This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2010 May 15;89(9):1166-7.

doi: 10.1097/TP.0b013e3181d2fed7.

Case report: drug interaction between tacrolimus and amiodarone with QT prolongation

Cathy I Burger, Catherine M Clase, Azim S Gangji

PMID: 20440199
DOI: 10.1097/TP.0b013e3181d2fed7

Case Reports

Case report: drug interaction between tacrolimus and amiodarone with QT prolongation

Cathy I Burger et al. Transplantation. 2010.

. 2010 May 15;89(9):1166-7.

doi: 10.1097/TP.0b013e3181d2fed7.

Authors

Cathy I Burger, Catherine M Clase, Azim S Gangji

PMID: 20440199
DOI: 10.1097/TP.0b013e3181d2fed7

No abstract available

PubMed Disclaimer

Similar articles

QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F. Kounas SP, et al. Pacing Clin Electrophysiol. 2005 May;28(5):472-3. doi: 10.1111/j.1540-8159.2005.09348.x. Pacing Clin Electrophysiol. 2005. PMID: 15869686
Amiodarone-induced long QT and polymorphic ventricular tachycardia.
Nkomo VT, Shen WK. Nkomo VT, et al. Am J Emerg Med. 2001 May;19(3):246-8. doi: 10.1053/ajem.2001.22655. Am J Emerg Med. 2001. PMID: 11326361 No abstract available.
Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient.
Nalli N, Stewart-Teixeira L, Dipchand AI. Nalli N, et al. Pediatr Transplant. 2006 Sep;10(6):736-9. doi: 10.1111/j.1399-3046.2006.00561.x. Pediatr Transplant. 2006. PMID: 16911499
Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ. Riera AR, et al. Cardiol J. 2008;15(3):209-19. Cardiol J. 2008. PMID: 18651412 Review.
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E, Watson T, Lip GY. Shantsila E, et al. Europace. 2007 Sep;9 Suppl 4:iv37-44. doi: 10.1093/europace/eum169. Europace. 2007. PMID: 17766322 Review.

See all similar articles

Cited by

Epidemiology and Prognostic Importance of Atrial Fibrillation in Kidney Transplant Recipients: A Meta-Analysis.
Thongprayoon C, Chokesuwattanaskul R, Bathini T, Khoury NJ, Sharma K, Ungprasert P, Prasitlumkum N, Aeddula NR, Watthanasuntorn K, Salim SA, Kaewput W, Koller FL, Cheungpasitporn W. Thongprayoon C, et al. J Clin Med. 2018 Oct 19;7(10):370. doi: 10.3390/jcm7100370. J Clin Med. 2018. PMID: 30347721 Free PMC article.
Simultaneous atrial fibrillation and sinus rhythm in a heart transplant recipient: ablation guided by novel dispersion analysis: a case report.
Heil E, Gerds-Li JH, Schoenrath F, Knosalla C, Hohendanner F. Heil E, et al. Eur Heart J Case Rep. 2025 Mar 26;9(4):ytaf152. doi: 10.1093/ehjcr/ytaf152. eCollection 2025 Apr. Eur Heart J Case Rep. 2025. PMID: 40213093 Free PMC article.
Recommendations on the use of azole antifungals in hematology-oncology patients.
Azanza JR, Mensa J, Barberán J, Vázquez L, Pérez de Oteyza J, Kwon M, Yáñez L, Aguado JM, Cubillo Gracian A, Solano C, Ruiz Camps I, Fortún J, Salavert Lletí M, Gudiol C, Olave Rubio T, Solano C, García-Vidal C, Rovira Tarrats M, Suárez-Lledó Grande M, González-Sierra P, Dueñas Gutiérrez C. Azanza JR, et al. Rev Esp Quimioter. 2023 Jun;36(3):236-258. doi: 10.37201/req/013.2023. Epub 2023 Apr 5. Rev Esp Quimioter. 2023. PMID: 37017117 Free PMC article. Review.
Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.
Jennings DL, Martinez B, Montalvo S, Lanfear DE. Jennings DL, et al. Heart Fail Rev. 2015 Sep;20(5):573-8. doi: 10.1007/s10741-015-9490-y. Heart Fail Rev. 2015. PMID: 25925244 Review.
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People.
Franchi C, Ardoino I, Rossio R, Nobili A, Biganzoli EM, Marengoni A, Marcucci M, Pasina L, Tettamanti M, Corrao S, Mannucci PM; REPOSI Investigators. Franchi C, et al. Drugs Aging. 2016 Jan;33(1):53-61. doi: 10.1007/s40266-015-0337-y. Drugs Aging. 2016. PMID: 26693921

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information